UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GCP
1851
DELISTED
GCP Applied Technologies Inc.
GCP
| $1.42M | ﹤0.01% |
58,051
| – | – |
|
1852
Stewart Information Services
STC
$2.08B
| $1.42M | ﹤0.01% |
27,320
| – | – |
|
1853
G-III Apparel Group
GIII
$1.5B
| $1.42M | ﹤0.01% |
47,151
-1,954
| -4% | -$56.9K |
|
|
MDP
1854
DELISTED
Meredith Corporation
MDP
| $1.41M | ﹤0.01% |
47,499
-4,740
| -9% | -$125K |
|
1855
Core Laboratories
CLB
$521M
| $1.41M | ﹤0.01% |
49,075
-3,095
| -6% | -$106K |
|
1856
Phreesia
PHR
$773M
| $1.41M | ﹤0.01% |
27,057
+5,457
| +25% | +$344K |
|
1857
Fortuna Silver Mines
FSM
$3.07B
| $1.41M | ﹤0.01% |
217,210
+100
| +0% | +$753 |
|
1858
Axsome Therapeutics
AXSM
$10.9B
| $1.41M | ﹤0.01% |
24,847
-2,196
| -8% | -$154K |
|
1859
TTM Technologies
TTMI
$14.5B
| $1.4M | ﹤0.01% |
96,738
-7,864
| -8% | -$111K |
|
|
CSGS
1860
DELISTED
CSG Systems International
CSGS
| $1.4M | ﹤0.01% |
31,228
+898
| +3% | +$41.4K |
|
1861
Enterprise Financial Services Corp
EFSC
$2.39B
| $1.39M | ﹤0.01% |
28,201
+4,762
| +20% | +$201K |
|
1862
AAR Corp
AIR
$5.76B
| $1.39M | ﹤0.01% |
33,424
-290
| -0.9% | -$11.5K |
|
|
SAFE
1863
Safehold
SAFE
$1.15B
| $1.39M | ﹤0.01% |
16,079
+86
| +0.5% | +$6.9K |
|
1864
Angi Inc
ANGI
$196M
| $1.39M | ﹤0.01% |
10,700
-252
| -2% | -$36.6K |
|
1865
V2X
VVX
$2.65B
| $1.39M | ﹤0.01% |
26,000
| – | – |
|
1866
Madrigal Pharmaceuticals
MDGL
$11.8B
| $1.38M | ﹤0.01% |
11,823
+2,122
| +22% | +$247K |
|
1867
Sturm, Ruger & Co
RGR
$593M
| $1.38M | ﹤0.01% |
20,844
| – | – |
|
1868
Otter Tail
OTTR
$3.94B
| $1.38M | ﹤0.01% |
29,826
| – | – |
|
1869
CNA Financial
CNA
$14.1B
| $1.38M | ﹤0.01% |
30,814
| – | – |
|
1870
Alphatec Holdings
ATEC
$1.44B
| $1.37M | ﹤0.01% |
86,996
+32,396
| +59% | +$510K |
|
|
AAMI
1871
Acadian Asset Management
AAMI
$3.19B
| $1.37M | ﹤0.01% |
67,201
+7,600
| +13% | +$150K |
|
1872
City Holding Co
CHCO
$2.04B
| $1.37M | ﹤0.01% |
16,728
| – | – |
|
1873
iShares MSCI Poland ETF
EPOL
$818M
| $1.37M | ﹤0.01% |
+75,539
| New | +$1.44M |
|
|
ECOL
1874
DELISTED
US Ecology, Inc.
ECOL
| $1.37M | ﹤0.01% |
32,801
| – | – |
|
1875
GoPro
GPRO
$126M
| $1.36M | ﹤0.01% |
117,011
-13,314
| -10% | -$126K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.